| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/12/2009 | US20090069564 Methods and Compositions for Selectin Inhibition |
| 03/12/2009 | US20090069415 Deuterium-enriched nebivolol |
| 03/12/2009 | US20090069404 Atrial fibrillation |
| 03/12/2009 | US20090069397 Deuterium-enriched olmesartan |
| 03/12/2009 | US20090069389 Novel controlled release-niacin formulation |
| 03/12/2009 | US20090069383 Thrombin Receptor Antagonists |
| 03/12/2009 | US20090069382 Bicyclic Angiotensin II Agonists |
| 03/12/2009 | US20090069376 Substituted N [N-(sulphonylphenyl)sulfonyl-prolyl]-phenylalanine derivatives are antagonists of the very late antigen-4 integrin; ulcerative colitis, Crohn's disease, asthma, multiple sclerosis, rheumatoid arthritis |
| 03/12/2009 | US20090069373 Quinoline Acids |
| 03/12/2009 | US20090069371 Isoquinoline compounds |
| 03/12/2009 | US20090069369 Deuterium-enriched prasugrel |
| 03/12/2009 | US20090069368 Fgf-receptor agonist dimeric compounds |
| 03/12/2009 | US20090069362 Novel Spiro-benzo[c]chromene derivatives useful as modulators of the estrogen receptors |
| 03/12/2009 | US20090069355 Bicyclic pyrazolone cytokine inhibitors |
| 03/12/2009 | US20090069353 Deuterium-enriched ambrisentan |
| 03/12/2009 | US20090069352 Deuterium-enriched clazosentan |
| 03/12/2009 | US20090069348 Use of Inhibitors of the Renin-Angiotensin System |
| 03/12/2009 | US20090069342 1-N-amino-2-imidazolidinones and derivatives thereof which are effective as Kv1.5 potassium channel inhibitors providing atrial-selective antiarrhythmic agents; 1-(aminosulfonylamino)-3-[2-(4-methoxyphenyl)ethyl]-4-(3,4-dimethylphenyl)-2-imidazolidinone |
| 03/12/2009 | US20090069338 Method for predicting skin sensitizing activity of compounds |
| 03/12/2009 | US20090069331 Guanidine derivatives as inhibitors of ddah |
| 03/12/2009 | US20090069329 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity |
| 03/12/2009 | US20090069325 Piperidine Derivatives Useful as Modulators of Chemokine Receptor Activity |
| 03/12/2009 | US20090069312 Potassium Channel Inhibitors |
| 03/12/2009 | US20090069305 Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor |
| 03/12/2009 | US20090069303 Phthalazinone derivatives |
| 03/12/2009 | US20090069285 Diphenylazetidinone Derivatives Possessing Cholesterol Absorption Inhibitor Activity |
| 03/12/2009 | US20090069283 Potassium Channel Inhibitors |
| 03/12/2009 | US20090069242 Therapeutically active alpha msh analogues |
| 03/12/2009 | US20090069235 IGF-1 Fusion Polypeptides and Therapeutic Uses Thereof |
| 03/12/2009 | US20090069225 Somatostatin analogues |
| 03/12/2009 | US20090068289 Formulation for menopausal women |
| 03/12/2009 | US20090068273 Prophylaxis of respiratory disorders such as asthma; composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent; 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol or salt |
| 03/12/2009 | US20090068260 Beta-1-selective adrenoceptor blocking agent compositions and methods for their preparation |
| 03/12/2009 | US20090068248 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same |
| 03/12/2009 | US20090068207 Compositions Containing Beta 2-Glycoprotein I-Derived Peptides for the Prevention and/or Treatment of Vascular Disease |
| 03/12/2009 | US20090068205 Antiproliferative agents; anticancer agents; composition comprising antagonist of a human ErbB4 receptor, in admixture with a pharmaceutically acceptable carrier; antagonist selected from group consisting of an antibody produced by a hybridoma selected from the group containing HER4.10H1.1A1 |
| 03/12/2009 | US20090068203 Methods for treating cardiovascular disease using a soluble CTLA4 Molecule |
| 03/12/2009 | US20090068193 Treatment And Prophylaxis With 4-1BB-Binding Agents |
| 03/12/2009 | US20090068152 Gene transfer for regulating smooth muscle tone |
| 03/12/2009 | US20090068139 LOOP PEPTIDE AND TGF alpha FOR STIMULATING STEM CELL PROLIFERATION AND MIGRATION |
| 03/12/2009 | US20090068101 A1 Adenosine Receptor Antagonists |
| 03/12/2009 | US20090068097 Method for non-invasive detection and treatment of cerebral aneurysms |
| 03/12/2009 | DE102007042754A1 Substituierte 6-Phenylnikotinsäuren und ihre Verwendung Substituted 6-Phenylnikotinsäuren and their use |
| 03/12/2009 | CA2698665A1 Pharmaceutical composition for inhibiting amyloid-beta protein accumulation |
| 03/12/2009 | CA2697929A1 Use of urate oxidase for the treatment or prophylaxis of disorders or indirect sequelae of the heart caused by ischemic or reperfusion events |
| 03/11/2009 | EP2033951A2 2-Piperazine-pyridines useful for treating pain |
| 03/11/2009 | EP2033653A1 A chinese medicine composition and preparation method and use thereof |
| 03/11/2009 | EP2033650A1 Inhibitor of expression of nuclear transcription factor ap-1, and pharmaceutical product and product using the inhibitor |
| 03/11/2009 | EP2033644A1 Spiroindene and spiroindane compounds |
| 03/11/2009 | EP2033643A1 Compressed preparation |
| 03/11/2009 | EP2033634A1 Agent for increasing testosterone level |
| 03/11/2009 | EP2033633A2 Partial fatty acid oxidation inhibitors in the treatment of congestive heart failure |
| 03/11/2009 | EP2033632A1 5-HT3 receptor antagonists for the teatment of myocardial infarction, stroke, thrombosis and atherosclerosis |
| 03/11/2009 | EP2033631A2 Pravastatin pharmaceutical formulations and methods of their use |
| 03/11/2009 | EP2033526A1 Nutritional products comprising pomegranate extracts containing ellagitannins and their use |
| 03/11/2009 | EP2032593A1 Amino derivatives of b-homoandrostanes and b-heteroandrostanes |
| 03/11/2009 | EP2032572A1 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them |
| 03/11/2009 | EP2032530A1 Pyrrolidine compounds as renin inhibitors |
| 03/11/2009 | EP1934207B1 Substituted 4-phenyl piperidines for use as renin inhibitors |
| 03/11/2009 | EP1814877B1 Diphenyl substituted alkanes as flap inhibitors |
| 03/11/2009 | EP1667770B1 Method for the production of derivatives of 4a,5,9,10,11,12-hexahydrobenzofuro [3a,3,2][ 2]- benzazepine |
| 03/11/2009 | EP1485364B1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 03/11/2009 | EP1485096B1 Methods for preventing or treating cardiac arrhythmia |
| 03/11/2009 | EP1379550B1 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 03/11/2009 | EP1349840B1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 03/11/2009 | EP1305409B1 Renal regulatory elements and methods of use thereof |
| 03/11/2009 | EP1268799B1 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability |
| 03/11/2009 | CN101384603A Novel, acyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases |
| 03/11/2009 | CN101384602A Novel, cyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases |
| 03/11/2009 | CN101384594A Condensed heterocyclic compounds useful as dpp-iv inhibitors |
| 03/11/2009 | CN101384259A Thrombin receptor antagonists as prophylaxis to complications from cardiopulmonary surgery |
| 03/11/2009 | CN101384258A FGF-peceptor agonist dimeric compounds |
| 03/11/2009 | CN101381725A Circular dumbbell decoy oligodeoxynucleotide (CDODN) containing transcription DNA binding sites |
| 03/11/2009 | CN101381409A N-terminally chemically modified protein compositions and methods |
| 03/11/2009 | CN101381401A Biologically non-degradable peptide, angiotensin converting enzyme inhibitor, drug and functional food |
| 03/11/2009 | CN101381366A Benzimidazole derivative and its use as a ii receptor antagonist |
| 03/11/2009 | CN101381360A Grafts of plant polyphenol and weathered coal humic acid degradation product and grafting method |
| 03/11/2009 | CN101381356A Preparation method of simvastatin |
| 03/11/2009 | CN101381349A Dipfluzine addition salt and preparation method |
| 03/11/2009 | CN101381332A Ibutilide fumarate synthetic process |
| 03/11/2009 | CN101380477A Use of CR-1 siRNA in treating myocardial hypertrophy induced by AngII |
| 03/11/2009 | CN101380455A Formulation for treating apoplexy |
| 03/11/2009 | CN101380454A Formulation for treating apoplexy |
| 03/11/2009 | CN101380446A Formulation for treating apoplexy |
| 03/11/2009 | CN101380445A Formulation for treating apoplexy |
| 03/11/2009 | CN101380444A Formulation for treating apoplexy |
| 03/11/2009 | CN101380438A Medicine composition for treating palsy hemiplegia due to cardiac and cerebral vessels and preparation method thereof |
| 03/11/2009 | CN101380435A Formulation for treating apoplexy |
| 03/11/2009 | CN101380428A Traditional Chinese medicine for treating hypotension |
| 03/11/2009 | CN101380423A Formulation for treating apoplexy |
| 03/11/2009 | CN101380413A Formulation for treating apoplexy |
| 03/11/2009 | CN101380412A Formulation for treating apoplexy |
| 03/11/2009 | CN101380410A Medicine for treating hyperactivity of fire due to yin deficiency and preparation method of the formulation thereof |
| 03/11/2009 | CN101380401A Traditional Chinese medicament for treating hemiplegia and cerebral palsy |
| 03/11/2009 | CN101380398A Composition for prevention and treatment of cardio-cerebrolvascular disease |
| 03/11/2009 | CN101380396A Pudendum powder and preparation method thereof |
| 03/11/2009 | CN101380391A Traditional Chinese medicine external application paste for treating angiitis |
| 03/11/2009 | CN101380379A Total flavone in leaves of Murraya paniculata (L.) Jack and preparation method and use thereof |
| 03/11/2009 | CN101380372A Pharmaceutical composition for treating cervical vertebra disease and its preparation method |
| 03/11/2009 | CN101380360A Total salvianolic acid drop pills and preparation method thereof |